Search
Now showing items 1-3 of 3
Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents?
(Walter de Gruyter GMBH, 2020)
Objectives: Copeptin, the C-terminal part of arginine-vasopressin, is increased in hypertensive adolescents and closely associated with metabolic syndrome (MS). We aimed to investigate whether serum copeptin can be used ...
Dynamic thiol/disulphide homeostasis as a novel indicator of oxidative stress in obese children and its relationship with inflammatory-cardiovascular markers
(Turkish Society of Cardiology, 2017)
Objective: Childhood obesity is an important cause of cardiovascular risk with chronic inflammation. Oxidative stress may contribute to the pathogenesis of obesity-related cardiovascular pathologies. We aimed to evaluate ...
Cardiometabolic risk factors in pediatric kidney transplant recipients
(AVES, 2023)
Objective: There is an increased risk of obesity and metabolic syndrome among kidney transplant recipients, which adversely affects cardiovascular and renal outcomes in these patients. The present study aims to investigate ...